OPS
JAZZ icon

Orion Portfolio Solutions’s Jazz Pharmaceuticals JAZZ Stock Holding History

Orion Portfolio Solutions’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$3.84M Buy
30,951
+326
+1% +$42.5K 0.04% 431
2024
Q4 		$3.77M Buy
30,625
+8,235
+37% +$971K 0.04% 412
2024
Q3 		$2.49M Sell
22,390
-1,986
-8% -$218K 0.02% 581
2024
Q2 		$2.6M Buy
24,376
+3,480
+17% +$383K 0.03% 526
2024
Q1 		$2.52M Buy
20,896
+688
+3% +$84.3K 0.03% 551
2023
Q4 		$2.54M Sell
20,208
-3,518
-15% -$439K 0.03% 522
2023
Q3 		$3.07M Sell
23,726
-157
-0.7% -$20.9K 0.04% 434
2023
Q2 		$2.96M Sell
23,883
-730
-3% -$98.2K 0.03% 490
2023
Q1 		$3.6M Buy
+24,613
New +$3.64M 0.04% 354
2020
Q3 		– Sell
-26
Closed -$3K – 1265
2020
Q2 		$3K Buy
26
+14
+117% +$1.55K ﹤0.01% 1656
2020
Q1 		$1K Sell
12
-3
-20% -$388 ﹤0.01% 1744
2019
Q4 		$2K Buy
+15
New +$2.04K ﹤0.01% 1520

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Orion Portfolio Solutions's JAZZ Position: Q1 2025 in Review

Orion Portfolio Solutions increased its Jazz Pharmaceuticals (JAZZ) stake by 1.1% in Q1 2025, buying an estimated $42.5K and bringing the position to 30,951 shares worth $3.84M. The position accounts for 0.04% of the portfolio, ranked #431.

Orion Portfolio Solutions first reported a position in JAZZ in Q4 2019 and has held it in 12 quarters since. 550 funds tracked by Wall St. Rank hold JAZZ as of Q1 2025.

  • Orion Portfolio Solutions held 30,951 shares of Jazz Pharmaceuticals worth $3.84M as of Q1 2025.
  • Orion Portfolio Solutions bought 326 Jazz Pharmaceuticals shares in Q1 2025, an estimated $42.5K.
  • Jazz Pharmaceuticals made up 0.04% of Orion Portfolio Solutions's portfolio in Q1 2025, its #431 holding.
  • Orion Portfolio Solutions first reported a position in Jazz Pharmaceuticals in Q4 2019 and has held it in 12 quarters since.
  • 550 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.